ClearPoint Neuro (CLPT) Operating Income Growth (1y) (2012 - 2026)
ClearPoint Neuro (CLPT) Operating Income Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.90 Bn | 176.61 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 128.85 Bn | 125.97 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 108.77 Bn | 99.55 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 68.39 Bn | 66.93 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.50 Bn | 44.83 Bn | 1.29 Bn | 20.97% |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn | -18.12% |
| 7 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 90.95% |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.35 Bn | 2.07 Bn | 74.18% |
| 10 | ClearPoint Neuro | 426.66 Mn | 391.06 Mn | 7.76 Mn | -37.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.56% |
| Dec 31, 2025 | -25.00% |
| Sep 30, 2025 | -2.29% |
| Jun 30, 2025 | -20.24% |
| Mar 31, 2025 | -46.18% |
| Dec 31, 2024 | -19.76% |
| Sep 30, 2024 | -5.33% |
| Jun 30, 2024 | 33.75% |
| Mar 31, 2024 | 26.19% |
| Dec 31, 2023 | -5.30% |
| Sep 30, 2023 | -29.04% |
| Jun 30, 2023 | -69.62% |
| Mar 31, 2023 | -47.83% |
| Dec 31, 2022 | -12.23% |
| Sep 30, 2022 | 0.24% |
| Jun 30, 2022 | -23.39% |
| Mar 31, 2022 | -77.17% |
| Dec 31, 2021 | -75.81% |
| Sep 30, 2021 | -199.06% |
| Jun 30, 2021 | -130.98% |